Windlas Biotech: ICICI Pru MF Cuts Stake, Holding Falls to 4.33%

OTHER
Whalesbook Corporate News Logo
AuthorIshaan Verma|Published at:
Windlas Biotech: ICICI Pru MF Cuts Stake, Holding Falls to 4.33%
Overview

ICICI Prudential Mutual Fund has significantly reduced its stake in Windlas Biotech Ltd., selling 1,44,516 shares on May 13, 2026. This divestment brings the fund's total holding to 4.33% (voting rights), marking a 2.63% decrease. While the fund cited investment perspective and not control, such moves by large institutions can influence market sentiment.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

ICICI Prudential Mutual Fund sold 1,44,516 shares of Windlas Biotech on May 13, 2026. This transaction lowered the fund's stake to 4.33% of the company's voting rights. Since July 30, 2024, the fund has divested a net total of 5,40,642 shares.

Following the disposal, Windlas Biotech's equity share capital saw a slight increase, moving from ₹10.45 crore to ₹10.55 crore.

Investor Takeaway

Sales by large institutional investors can shift market perception. Investors often view significant stake reductions as a sign of waning confidence or a strategic portfolio adjustment. These moves can influence short-term trading sentiment for Windlas Biotech's stock.

What to Track

Investors will be watching for further disclosures on ICICI Prudential Mutual Fund's stake. They will also monitor if other large investors adjust their holdings. Management commentary during upcoming calls and Windlas Biotech's financial performance will be key factors to track.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.